TerminatedPhase 2NCT01750346
Acetyl Hexapeptide-8 for Blepharospasm
Studying Focal, segmental or multifocal dystonia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Institute of Neurological Disorders and Stroke (NINDS)
- Principal Investigator
- Codrin I Lungu, M.D.National Institute of Neurological Disorders and Stroke (NINDS)
- Intervention
- Topical acetyl hexapeptide-8(drug)
- Enrollment
- 8 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2012 – 2015
Study locations (1)
- National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01750346 on ClinicalTrials.govOther trials for Focal, segmental or multifocal dystonia
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07304089A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated DystoniaVima Therapeutics
- RECRUITINGNANCT05095740Effects of Neuromodulation in Laryngeal DystoniaMGH Institute of Health Professions
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT02911103Deep Brain Stimulation Surgery for Focal Hand DystoniaNational Institute of Neurological Disorders and Stroke (NINDS)
See all trials for Focal, segmental or multifocal dystonia →